logo

Gtx Inc. (GTXI)



Trade GTXI now with
  Date
  Headline
9/26/2017 7:33:16 AM GTx Enters Definitive Securities Purchase Agreement For Sale Of Common Stock And Warrants In Private Placement
9/13/2017 7:03:00 AM GTx Says Positive Results From GTx-024 Phase 2 Proof-of-Concept Clinical Trial In Women With Stress Urinary Incontinence
8/14/2017 7:11:32 AM GTx, Inc. Q2 Net Loss $6.4 Mln Vs. Net Loss $6.1 Mln Last Year
6/12/2017 7:11:04 AM GTx Says Positive Preliminary Results From Phase 2 Clinical Trial In Women With Stress Urinary Incontinence
3/15/2017 7:07:15 AM GTx Q4 Net Loss $6.9 Mln Vs. Net Loss Of $3.2 Mln Prior Year
12/5/2016 8:38:39 AM GTx Announces Reverse Stock Split Of Its Shares At Ratio Of One-for-ten
11/28/2016 7:10:03 AM GTx: Enobosarm Meets Pre-Specified Primary Efficacy Endpoint In Phase 2 Trial In ER+/AR+ Breast Cancer
11/16/2016 7:05:41 AM GTx Unveils Achievement Of Second Stage 1 Milestone In Phase 2 Trial Of Enobosarm In ER+/AR+ Breast Cancer
11/3/2016 7:29:53 AM GTx, Inc. Q3 Net Loss $6.9 Mln Vs. Net Income $34.9 Mln Last Year
10/12/2016 7:02:42 AM GTx Plans $14.0 Mln Registered Direct Common Stock Offering
9/8/2016 7:04:17 AM GTx Says Achieves Stage 1 Milestone In Phase 2 Clinical Trial Of Enobosarm In ER+/AR+ Breast Cancer
8/9/2016 7:16:18 AM GTx, Inc. Q2 Net Loss Narrows To $6.1 Mln From $48.0 Mln Last Year
5/10/2016 7:12:08 AM GTx, Inc. Q1 Net Income $2.1 Mln Vs. Net Loss $2.4 Mln Last Year
3/3/2016 7:07:20 AM GTx, Inc. Q4 Net Loss $3.2 Mln Vs. Net Loss $14.5 Mln Last Year